Douglas Hughes

Douglas Hughes is currently Director at Immunovant Sciences Ltd. since 2019, Independent Director at Immunovant, Inc. since 2019, Chief Financial Officer & Director at Calyxo, Inc. since 2018, and Chief Financial Officer at Calyxo USA, Inc. since 2019.
Former roles include Director-Investor Relations at The Clorox Co., Independent Non-Executive Director at Eargo, Inc. from 2020 to 2022, Director at Immunovant, Inc., Vice President-Investor Relations at Guidant Corp., Vice President-Finance & Administration at Boston Scientific Corp., Chief Operating & Financial Officer at Nellix, Inc. from 2010 to 2011, Chief Financial Officer at NeoTract, Inc. from 2011 to 2018, Chief Financial Officer at Evalve, Inc. from 2009 to 2010, and Chief Financial Officer at Maquet.
Education includes an MBA from The University of Chicago and undergraduate studies at San Francisco State University.